Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Knee Osteoarthritis
NCT ID: NCT05398874
Last Updated: 2022-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2021-11-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee.
NCT02604381
Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee
NCT02845271
Efficacy Management and Adherence Evaluation of Diclofenac in the Treatment of Knee Osteoarthritis Pain
NCT03806205
Novel Transdermal Ketoprofen Gel Formulation for Knee Osteoarthritis
NCT07319728
The Efficacy of TGF for Treating Osteoarthritis of the Knee
NCT03562429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ginkgo + standard
the patients received Ginkgo biloba extract in addition to standard treatment
Ginkgo biloba extract + standard treatment( paracetamol+Diclofenac100mg SR)
120 mg leaf extract , twice daily in addition to Diclofenac 100 mg Once daily + paracetamol 1g Twice daily
placebo + standard
the patients received a placebo in addition to the standard treatment
placebo in addition to the standard treatment
placebo in addition to the standard treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginkgo biloba extract + standard treatment( paracetamol+Diclofenac100mg SR)
120 mg leaf extract , twice daily in addition to Diclofenac 100 mg Once daily + paracetamol 1g Twice daily
placebo in addition to the standard treatment
placebo in addition to the standard treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Grade II and Grade III according to the Kellgrenn-Lawrence (KL) grading system of radiographic OA.
Exclusion Criteria
* Liver or renal problems
* Patient taking any drug that might interact with Ginkgo extract (eg. warfarin, etc.)
* patient with cardiovascular or cerebral vascular disorders, uncontrolled diabetes, allergic to ginkgo, recent surgery or hospital admission, \>75 years old.
* Allergic or contraindicated to using NSAIDs
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kufa University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maryam Al-Haddad
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Private Clinic
Najaf, N/A (Outside of US), Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEC-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.